News

Zealand Pharma's Upcoming Investor Conference Schedule

Zealand Pharma's Upcoming Investor Conference Schedule

Zealand Pharma's Upcoming Investor Conference Schedule

Zealand Pharma A/S (Nasdaq: ZEAL), a pioneering biotechnology company, is gearing up for an exciting series of investor conferences this September. With its commitment to the research and development of innovative peptide-based medicines, Zealand Pharma aims to engage with investors and showcase its latest advancements in the biotechnology sector.

Key Conferences in September

In September 2025, Zealand Pharma will participate in several high-profile investor conferences, designed to promote its innovative drug discovery initiatives. These conferences present an excellent opportunity for investors to gain insights directly from the company's leadership.

Jefferies Swiss Healthcare Summit 2025

This summit, taking place on September 3, will feature Adam Lange, Vice President of Investor Relations. He will conduct investor meetings throughout the day, providing attendees with an in-depth understanding of the company’s strategic direction and growth potential.

Cantor Global Healthcare Conference 2025

Also scheduled for September 3-5 in New York, this conference will include Adam Steensberg, the President and Chief Executive Officer of Zealand Pharma. On September 4, he is set to host meetings with investors, as well as partake in a fireside chat at 8:00am EDT (14:00 CET). The chat promises to be an engaging discussion about the current landscape of the biotechnology industry and Zealand Pharma's role within it.

Wells Fargo and Morgan Stanley Conferences

Following these events, Zealand Pharma will also participate in the 2025 Wells Fargo Healthcare Conference from September 3 to 5 in Boston. During this important gathering, Adam Steensberg will engage with investors on September 5 and contribute to a fireside chat at 8:45am EDT (14:45 CET).

Morgan Stanley Annual Healthcare Conference

Adam Lange will lead investor engagements at the Morgan Stanley Annual Healthcare Conference on September 10 in New York. This event will allow for valuable interactions between the company's leadership and potential investors.

Final Conferences and Presentations

Later in the month, Zealand Pharma will partake in the Bank of America Global Healthcare Conference from September 23 to 25 in London. David Kendall, Executive Vice President and Chief Medical Officer, will run meetings on September 24 and 25 and is scheduled to give a presentation on September 25 at 10:45 am UKT (11:45 CET). Additionally, an audio webcast link will be available for viewing later on the company’s website, allowing for broader access to interested parties.

KBC Securities Life Sciences Conference

The final conference in September will be the KBC Securities Life Sciences Conference in Brussels on September 25. Adam Lange will again represent the company, hosting meetings with investors to deepen connections and share updates on Zealand Pharma’s innovative portfolio.

About Zealand Pharma

Established in 1998 and headquartered in Copenhagen, Zealand Pharma A/S (Nasdaq: ZEAL) concentrates on the development of peptide-based drugs. Over the years, the company has successfully brought several drug candidates into clinical progress, with two gaining market approval and three in late-stage development phases. Its partnerships with various pharmaceutical companies enhance its market reach and operational capacity.

For additional details about Zealand Pharma, including updates on its initiatives and conferences, please visit www.zealandpharma.com.

Frequently Asked Questions

What is the focus of Zealand Pharma?

Zealand Pharma is dedicated to the discovery and development of innovative peptide-based medicines aimed at addressing unmet medical needs.

When will Zealand Pharma participate in its next investor conference?

Zealand Pharma will participate in several conferences throughout September, starting with the Jefferies Swiss Healthcare Summit on September 3.

Who will represent Zealand Pharma at these conferences?

Key representatives include Adam Lange, Vice President of Investor Relations, and Adam Steensberg, President and Chief Executive Officer.

Are there any webcasts available for the fireside chats?

Yes, there will be live audio webcasts for some sessions, with recordings available after the events for those unable to attend.

How many drug candidates has Zealand Pharma developed?

Zealand Pharma has pushed over ten drug candidates into clinical development, with several achieving market readiness.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Tim Hortons Bets on ELF Cheer for U.S. Holiday Visits

Updated Category News Views 15

Nothing says holiday restaurant marketing quite like putting spaghetti-shaped whipped topping on hot chocolate and trusting a 2003 movie to do the selling. Tim Hortons is rolling out an ELF-inspired menu at participating U.S. locations starting November 18, 2026, pairing the chain with Warner Bros. Consumer Products and mining Buddy the Elf's sugar-fueled world for a...

Continue Reading
MetaComp Targets ASEAN's Cross-Border Payment Snarl

Updated Category News Views 53

ASEAN payment plumbing is still a patchwork, and MetaComp is betting that patchwork has finally become painful enough to fix. The Singapore-based payments firm says its StableX Agentic Network has topped 1,000 members and reaches more than 100,000 users in its first year. That is a respectable early footprint, not a victory lap. Cross-border payments are littered with...

Continue Reading
A Faded Sign Is a Quiet Leak in Storefront Demand Today

Updated Category News Views 95

Sunlight does not care what the marketing budget said. A storefront can have a decent product, a clean interior and a capable crew, then lose the first impression before anyone reaches the door because its sign looks tired. That is the plainspoken point behind FASTSIGNS' latest guidance on outdoor sign lifespan. This is not glamorous stuff, but it is operationally...

Continue Reading
A €18 Million Mecca Chandelier Tests Austrian Craft

Updated Category News Views 103

Scale Is Easy to Boast About, Delivery Is Not A 34.1-metre chandelier hanging in Mecca is the sort of job that makes ordinary project talk sound downright silly. Lights of Vienna says it designed, built, tested, shipped and installed this monster for the Grand Mosque's Shamiya area, with a contract value of roughly €18 million. That is a serious piece of work for a...

Continue Reading
Sinopec’s Algerian Outreach Reveals a Patient Long Game

Updated Category News Views 20

Soft Power Does Not Run a Refinery, but It Matters A short video contest in Algiers will not move an oilfield schedule or settle a hydrocarbons negotiation. That is precisely why this Sinopec-backed event deserves a sober look rather than a chest-thumping one. On Nov. 15, Sinopec Group and the Chinese Embassy in Algeria co-hosted the final of their second youth cultural...

Continue Reading
Linkind's Best Buy Push Tests Smart Outdoor Demand

Updated Category News Views 62

Holiday lights have quietly become a year-round hardware category, and Linkind wants a louder seat at the table. The smart-lighting brand says three outdoor products have been in Best Buy stores across the United States since October 17, 2026: permanent exterior lights, decorative string lights, and solar pathway lights. That is a real distribution step, not some grand...

Continue Reading
Sunbit’s 2027 Loan Push Meets an NVIDIA-Fueled Tape

Updated Category News Views 0

Credit Is About to Enter Sunbit’s Growth Story Sunbit has spent years building a point-of-sale fintech footprint, and the numbers it cited on November 18 make the next step harder to dismiss as mere marketing fluff. The company says it has topped 400,000 activated cardholders and 50,000 merchants, while expecting more than $440 million in fiscal 2026 sales on greater...

Continue Reading
Nellie's 50% Booking Jump Reveals a Quieter Luxury

Updated Category News Views 6

Silicon Valley’s rich are apparently tired of performing wealth for strangers, and frankly, that tracks. Nellie’s 2027 forecast says its mostly tech-money clientele is moving past the old trophy case of private jets, famous resort towns, and suites priced like small houses. The prize now is privacy, a clean schedule, and somebody competent fixing the ugly little...

Continue Reading
Hanon's BMW Thermal Win Matters Beyond the Trophy Case Today

Updated Category News Views 96

A 16-Kilogram Box Just Grabbed the Auto Supply Chain’s Attention Hanon Systems did not win these two 2026 PACE honors by polishing up some old hose-and-valve package. Its Highly Integrated Cooling Entity, or HICE, is aimed right at a stubborn electric-vehicle problem: keeping a vehicle’s thermal systems controlled without turning the architecture into a sprawling,...

Continue Reading
LG Channels UAE Push Tests the Free Streaming Model

Updated Category News Views 42

A television's idle screen is turning into contested real estate in the UAE. LG Channels is adding programming from Rakuten TV, Stingray and Red Bull TV to its free, ad-supported service, and that matters for more than somebody hunting a movie after dinner. This is a practical push to make webOS-powered screens more useful, more frequently used and, eventually, more...

Continue Reading

Top 5 Most Recently Viewed Articles

A.B. Data Appoints Steve Straub as New Operations VP

Updated Category News Views 542

A.B. Data Appoints Steve Straub as New Operations VP A.B. Data, a prominent name in class action notice and claims administration, has elevated Steve Straub to the role of Vice President of Operations. Having served as the Senior Director of Operations since 2023, Steve brings a wealth of experience that will further strengthen the company’s operations. Strategic...

Continue Reading
Conexon Connect Expands Fiber Network for Rural Internet Access

Updated Category News Views 170

Conexon Connect's Milestone Achievement Conexon Connect has successfully completed a transformative fiber-to-the-home (FTTH) project, expanding high-speed internet access to over 12,000 members of rural electric cooperatives. This expansive network marks a significant achievement in bridging the digital divide, particularly for underserved communities. Partnerships...

Continue Reading
Xiaomi MIX Flip 2 Unveils TCL CSOT's Cutting-Edge Displays

Updated Category News Views 349

TCL CSOT Powers the Xiaomi MIX Flip 2's Display Experience TCL CSOT is making waves in the tech world by providing state-of-the-art displays for the Xiaomi MIX Flip 2. This new foldable smartphone marks a significant shift in user experiences, aligning perfectly with the growing demand for portable, high-performance devices. During a recent launch event showcasing...

Continue Reading
Immunic Showcases Promising Results for Vidofludimus Calcium

Updated Category News Views 106

Immunic Highlights Key Findings from CALLIPER Trial Immunic, Inc. (Nasdaq: IMUX), a leading biotechnology company specializing in innovative oral therapies for neurologic and gastrointestinal conditions, recently presented significant data from its Phase 2 CALLIPER trial. This trial evaluates its cornerstone therapy, vidofludimus calcium (IMU-838), aimed at treating...

Continue Reading
Amrop Expands Global Reach with New Office in Colombia

Updated Category News Views 153

Amrop Expands With a New Office in Colombia Amrop, a distinguished global executive search and leadership consulting firm, has recently announced the establishment of a new office in Colombia. This expansion marks a significant milestone for Amrop as they enhance their service offerings in Latin America. Introducing Amrop Colombia Amrop Colombia emerges from the merger...

Continue Reading